Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Quattrone, Diego
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.734
EU - Europa 2.423
AS - Asia 1.942
SA - Sud America 422
AF - Africa 71
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.664
IT - Italia 810
SG - Singapore 783
CN - Cina 515
DE - Germania 512
BR - Brasile 344
RU - Federazione Russa 314
HK - Hong Kong 266
PL - Polonia 223
GB - Regno Unito 136
VN - Vietnam 104
FI - Finlandia 73
FR - Francia 65
NL - Olanda 48
IE - Irlanda 45
IN - India 43
AT - Austria 38
CA - Canada 31
SE - Svezia 31
TR - Turchia 31
KR - Corea 29
RO - Romania 29
AR - Argentina 28
ES - Italia 27
BD - Bangladesh 24
MX - Messico 24
JP - Giappone 21
CI - Costa d'Avorio 20
IQ - Iraq 18
UA - Ucraina 16
EC - Ecuador 15
ZA - Sudafrica 14
MY - Malesia 13
GR - Grecia 11
TW - Taiwan 11
ID - Indonesia 10
BE - Belgio 9
EG - Egitto 9
IR - Iran 9
CH - Svizzera 8
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
VE - Venezuela 8
MA - Marocco 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
LT - Lituania 6
PK - Pakistan 6
AL - Albania 5
CO - Colombia 5
JM - Giamaica 5
BG - Bulgaria 4
KZ - Kazakistan 4
PE - Perù 4
UY - Uruguay 4
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
EU - Europa 3
PT - Portogallo 3
CZ - Repubblica Ceca 2
GE - Georgia 2
KG - Kirghizistan 2
LV - Lettonia 2
NE - Niger 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NA - Namibia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SO - Somalia 1
Totale 8.598
Salva come PNG Salva come JPEG
Città #
Ashburn 566
Singapore 474
Fairfield 460
Hong Kong 254
Chandler 225
Palermo 217
Zgierz 206
Woodbridge 196
Houston 185
Wilmington 159
Seattle 157
Dallas 132
Ann Arbor 126
Cambridge 126
Hefei 110
Beijing 100
Moscow 89
Los Angeles 83
Medford 76
Lappeenranta 59
Rome 58
Boardman 55
Buffalo 49
Des Moines 47
Altamura 45
Ho Chi Minh City 44
Princeton 44
Dublin 43
Chicago 41
Lawrence 41
San Diego 36
Santa Clara 36
New York 35
Milan 33
Nuremberg 33
The Dalles 31
London 30
São Paulo 29
Seoul 28
Ludwigshafen am Rhein 27
Hanoi 22
Abidjan 20
Columbus 16
Council Bluffs 16
Florence 15
Frankfurt am Main 15
Redwood City 15
Alimena 14
Amsterdam 14
Rio de Janeiro 14
Vienna 14
Brooklyn 13
Dearborn 13
Falls Church 13
Salt Lake City 13
San Paolo di Civitate 13
Helsinki 12
Johannesburg 12
Nanjing 12
Tokyo 12
Warsaw 12
Atlanta 11
Messina 11
Tower Hamlets 11
Central 10
Phoenix 10
Redondo Beach 10
Washington 10
Istanbul 9
Munich 9
Naples 9
Turin 9
Brussels 8
Kumar 8
Poplar 8
Alcalá de Henares 7
Amman 7
Bari 7
Bologna 7
Boston 7
Elk Grove Village 7
Guangzhou 7
Mexico City 7
Noblesville 7
Paris 7
Saint Petersburg 7
Tainan City 7
Tianjin 7
Toronto 7
Belo Horizonte 6
Denver 6
Erbil 6
Groningen 6
Montreal 6
Orem 6
Pescara 6
Recife 6
Ribeirão Preto 6
Shenyang 6
Stockholm 6
Totale 5.382
Salva come PNG Salva come JPEG
Nome #
Interplay Between Childhood Maltreatment, Subclinical Post-Traumatic Stress Symptoms, and IQ: Findings From the EU-GEI Multicentre Case–Control Study 377
Treated incidence of psychotic disorders in the multinational EU-GEI study 248
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 247
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 208
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 202
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 193
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 192
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 189
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 187
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 185
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 178
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 175
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 173
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 170
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 167
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia 164
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 164
Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project 160
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 159
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 156
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 149
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 148
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings 138
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 135
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 130
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 129
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study 121
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 120
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 114
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 111
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 106
Beyond the Gender Binarism: Neural Correlates of Trans Men in a Functional Connectivity–Resting-State fMRI Pilot Study 103
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 103
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 103
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 98
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 93
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 92
The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: Findings from the multinational EU-GEI study 92
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 89
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors 85
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 84
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 81
Migration history and risk of psychosis: Results from the multinational EU-GEI study 81
Neurobiological and Anti-Inflammatory Effects of a Deep Diaphragmatic Breathing Technique Based on Neofunctional Psychotherapy: A Pilot RCT 80
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 79
BEHAVIOURAL PREDICTORS OF WEIGHT LOSS MAINTENANCE AFTER BARIATRIC SURGERY: A SCOPING REVIEW 78
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 77
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study 76
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 73
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 72
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 71
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings 70
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 70
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IN FIRST-EPISODE PSYCHOSIS: LONGITUDINAL INSIGHTS FROM THE GAP FOLLOW-UP STUDY 69
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 67
58.1 Cannabis use Across Europe: A Ticket to Psychosis? 67
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia 66
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 64
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 64
Early parental death and risk of psychosis in offspring: A six-country case-control study 62
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 62
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 62
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education 61
A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders 61
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 59
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 57
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 56
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study 50
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 49
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 49
Tobacco use in first-episode psychosis, a multinational EU-GEI study 48
The Kraepelian concept of schizophrenia: Dying but not yet dead 48
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 47
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis 44
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis 43
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 43
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated with Common Genetic Variants for Major Psychiatric Conditions: Results from the Multi-Center EU-GEI Study 43
Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem 43
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 42
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 41
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis? 40
The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use 39
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma 38
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 38
Differential gene expression analysis in blood of first episode psychosis patients 37
SU132CANNABIS USE AND SCHIZOPHRENIA: CAN GENETICS TELL IF IS IT "THE CHICKEN OR THE EGG"? 36
Do Idiopathic Parkinson's Disease and Schizophrenia Lie on the Same Genetic Spectrum? 36
Does personality matter? Temperament and character dimensions in panic subtypes 35
Novel psychoactive substances in young adults with and without psychiatric comorbidities 35
The effect of the COVID-19 pandemic on the treated incidence of psychotic disorders in South London 35
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe 34
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 34
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study 34
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder 33
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? 33
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study 33
First-generation antipsychotics and QTc: any role for mediating variables? 33
Substance-induced psychosis and schizophrenia: the interaction point 33
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies 32
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study 32
Totale 9.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021631 0 0 0 0 0 40 162 112 80 97 64 76
2021/2022729 46 93 30 34 34 67 28 110 58 62 61 106
2022/2023852 82 151 32 58 82 149 60 52 92 16 61 17
2023/2024773 14 50 17 79 46 58 89 33 1 54 38 294
2024/20251.944 167 80 82 157 81 76 158 147 172 220 213 391
2025/20263.104 367 194 486 840 556 661 0 0 0 0 0 0
Totale 9.430